查詢結果分析
來源資料
頁籤選單縮合
題名 | 強度調控放射治療應用等效組織補償器對表面劑量正常器官劑量之影響=The Affect of Surface Dose and Normal Organ Dose in IMRT with Bolus |
---|---|
作者 | 賴鵬安; 王雅玲; 黃光偉; 邱仲峰; 葉啟源; 游澄清; | 書刊名 | 臺灣應用輻射與同位素雜誌 |
卷期 | 2:1 民95.03 |
頁次 | 頁13-19 |
分類號 | 414.93 |
關鍵詞 | 強度調控放射治療; 等效組織補償器; 表面劑量; 正常器官劑量; Intensity modulated radiation therapy; IMRT; Bolus; Surface dose; Dose of normal organ; |
語文 | 中文(Chinese) |
中文摘要 | 本文探討當病患腫瘤的位置在接近或是生長在皮膚表面,接受強度調控放射治療(Intensity Modulated Radiotherapy; IMRT)時,利用等效組織補償器(bolus)的效應提高病患皮膚表面劑量及對體內正常器官劑量分佈的影響。本文使用的設備包括Varian 21EX直線加速器治療能量為6MV,反算式治療計畫系統Eclipse TPS with Helios (Varian Medical Systems, Palo Alta, CA),PPC05平板型游離腔,Scanditronix Wellhofer Dose1電量計,GE Nxi電腦斷層模擬定位儀,以及固能水假體。測量深度從距離表面0mm、2mm、3mm、4mm、6mm、8mm、10mm及15mm共測量8個深度。另一組在假體加上0.5cm的等效組織補償器以相同的方式再測量一次,並其將測量值歸一化(normalize)在15mm的深度以比較表面劑量。同時和治療計畫電腦計算的結果比較計算值和測量值的差異。測量的結果顯示在假體中0-3mn處最大差異為50%,而加上等效組織補償器後最大差異只有4.8%。在4-6mn處有3%的差異;加上等效組織補償器的部份則有2%的差異。在治療計畫中表面劑量的比較上來看,有加等效組織補償器的可以在入射表面得到95%以上的劑量,而另一組沒有加等效組織補償器只能得到82%左右的劑量。腫瘤劑量分佈在最大和最低的比較上,使用等效組織補償器的治療計畫也較未使用的治療計畫好,其他正常器官如腦幹、脊椎、對側唾液腺等在劑量-體積直方圖(Dose-Volume Histogram)的比較來看並沒有太大的差異。但是在腫瘤同側的唾液腺加了等效組織補償器的計畫明顯的優另一組未加等效組織補償器的計畫。 |
英文摘要 | To investigate the patient with growing tumor near the surface or skin the affect of surface and normal organs dose in intensity modulated radiation therapy (IMRT) with bolus. Varian 21EX accelerator, Eclipse TPS with Helios inverse treatment planning system, PPC05 parallel ionization chamber, Scanditronix Wellhofer Dosel electrometer, GE NXi CT simulator solid water phantom was used in this study. The parallel-plate chamber measurements wree taken in a solid water phantom at depths of 0 mm (surface), 2-, 3-, 4-, 6-, 8-, 10-, and 15-mm along the central axis of the beam with and without bolus. The PDDs for the IMRT plan were low by 50%, 4.8% at 0-3mm compared to the measurement PDDs without and with bolus respectively. The PDDs for the IMRT paln were low by 3%, 2% at 4-6mm compared to the measurement PDDs without and with bolus respectively. This study showed that the treatment planning dose calculation algorithm did not accurately describe the superficial dose distribution. The IMRT doses calculated by the planning software were underestimated by compared to the doses measured by the parallel-plate chamber. Therefore, we suggest that surface and build-up region doses should be validated when the target volume extends to the skin and the target dose is required to cover the patient Extending to 3 mm depth, indicating that thin bolus might be necessary when the target dose is required at the patient surface. |
本系統之摘要資訊系依該期刊論文摘要之資訊為主。